Cargando…

A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models

Detalles Bibliográficos
Autores principales:	Fan, Jiansheng, Zhuang, Xinlei, Yang, Xiaoyue, Xu, Yingchun, Zhou, Zhan, Pan, Liqiang, Chen, Shuqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413295/ https://www.ncbi.nlm.nih.gov/pubmed/34475375 http://dx.doi.org/10.1038/s41392-021-00666-5

Ejemplares similares

Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
por: Zhuang, Xinlei, et al.
Publicado: (2022)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
por: Pymm, Phillip, et al.
Publicado: (2022)

Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab
por: Zhang, Ying, et al.
Publicado: (2019)

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
por: Wagner, Teresa R, et al.
Publicado: (2021)

JSKN003, A NOVEL BIPARATOPIC ANTI-HER2 ANTIBODY-DRUG CONJUGATE, EXHIBITS POTENT ANTITUMOR EFFICACY
por: Wang, Pilin, et al.
Publicado: (2023)

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
por: Schütze, Kerstin, et al.
Publicado: (2018)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
por: Sadeghnezhad, Golnaz, et al.
Publicado: (2019)

Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
por: Sánchez-García, Laura, et al.
Publicado: (2021)

Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening
por: Bogen, Jan P., et al.
Publicado: (2020)

TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation
por: Shen, Ying, et al.
Publicado: (2020)

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
por: Wang, Jiewen, et al.
Publicado: (2022)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
por: Puthenveetil, Sujiet, et al.
Publicado: (2017)

Nanobody-Displaying Flagellar Nanotubes
por: Klein, Ágnes, et al.
Publicado: (2018)

Evaluation and selection of potent fluorescent immunosensors by combining fluorescent peptide and nanobodies displayed on yeast surface
por: Inoue, Akihito, et al.
Publicado: (2021)

Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
por: Chen, Chuan, et al.
Publicado: (2022)

Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting
por: Kooijmans, Sander A. A., et al.
Publicado: (2016)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
por: Xu, Caili, et al.
Publicado: (2023)

A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms
por: Stefano, James E., et al.
Publicado: (2021)

Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH
por: Emmerson, Chris D., et al.
Publicado: (2011)

Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca naïve phage display library
por: Li, Qianlin, et al.
Publicado: (2022)

Sortase A transpeptidation produces seamless, unbranched biotinylated nanobodies for multivalent and multifunctional applications
por: Obeng, Eugene M., et al.
Publicado: (2023)

Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy
por: Bai, Xuefei, et al.
Publicado: (2021)

Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
por: Mitran, Bogdan, et al.
Publicado: (2018)

A Biparatopic Antibody–Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade
por: DaSilva, John O., et al.
Publicado: (2021)

Solid-Phase Synthesis of Self-Assembling Multivalent π-Conjugated Peptides
por: Sanders, Allix M., et al.
Publicado: (2017)

A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
por: Fu, Ying, et al.
Publicado: (2022)

Escherichia coli surface display for the selection of nanobodies
por: Salema, Valencio, et al.
Publicado: (2017)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Transient Multivalent Nanobody Targeting to CD206-Expressing Cells via PH-Degradable Nanogels
por: Scherger, Maximilian, et al.
Publicado: (2020)

A Viral Platform for Chemical Modification and Multivalent Display
por: Peabody, David S
Publicado: (2003)

Design and synthesis of multivalent neoglycoconjugates by click conjugations
por: Ding, Feiqing, et al.
Publicado: (2014)

Multivalent glycocyclopeptides: conjugation methods and biological applications
por: Goyard, David, et al.
Publicado: (2022)

Bp-Bs, a Novel T-cell Engaging Bispecific Antibody with Biparatopic Her2 Binding, Has Potent Anti-tumor Activities
por: Liu, Jiayu, et al.
Publicado: (2019)

Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017)

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
por: van Driel, Pieter B.A.A., et al.
Publicado: (2016)

Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
por: Koenig, Paul-Albert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0mcbu2vhuu8fmqqasikb7as8bo